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CASE REPORT 
ANAESTHETIC MANAGEMENT OF A PATIENT WITH 
PHAEOCHROMOCYTOMA AND UNCONTROLLED BLOOD 
PRESSURE 
Ursula Chohan and Fazal H Khan 
ABSTRACT: Anaesthetic management of phaeochromocytoma includes pre·operative preparation, intraoperative control and 
avoidance of drugs that cause hypotension or hypertension. A case of 46-year old male, with phaeochromocytoma is presented 
here highlighting issues in anaesthetic management. 
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INTRODUCTION 
Phaeochromocytomas are rare catecholamine secreting 
tumours of the adrenal medul1a1 • The incidence varies from 
0.1% to 0.8% in the hypertensive population1 • Majority of 
these tumours (85-90%) are located on adrenal gland. 
Approxi-mately 10% of adult patients and 25% of paediatric 
patients have bilateral tumours. Almost 90% of the tumours 
are found in the abdomen. Remaining 5% are found any-
where along the sympathetic tissue from the neck to the 
inguinal ligament. Biochemical tests and noninvasive localis-
ing methods are essential for the definite diagnosis of 
phaeochromocytoma. Surgical removal of the tumour is the 
only definite therapy with low morbidity and mortality. The 
initial successful operations for the removal of phaeochromo-
cytoma were performed by Cesar Raux and CH Mayo, in 
19263.4. 
In this report we describe a successful anaesthetic manage-
ment of a patient with phaeochromocytoma. 
CASE REPORT 
A 46 years old male, diagnosed case of phaeochromocytoma 
with paroxysmal hypertension, was admitted to control his 
recent symptom of breathlessness. He is an insulin dependent 
diebetic, and a heavy smoker. He also had one episode of 
chest pain, which radiated to the left arm, about 6 months 
ago. 
On examination there were bilateral rhonchi and tenderness 
in both hypochondriac regions. Electrocardiogram had evi-
dence of antero septal infarct. Ultrasound abdomen showed a 
non-visible left kidney and hypertrophied right kidney with a 
4 x 4.5 em mass at the upper pole. CT abdomen showed right 
adrenal mass with absent left kidney and a right sided pleural 
effusion. 
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The urinary catecho}amines were 2256 mg/24 hours (range 
10-270), urine VMA was 4340mg/24 hours (range 1.9-9.8), 
serum cortisol was 23.9 (3.25) and S.DHEA S04 was 35.8 
(range 80-560). 
Echocardiography showed left ventricular hypertrophy, 
severe left ventricular dysfunction with ejection fraction of 
16%. The septum and the apex of the heart were dyskinetic. 
The coronary angiography revealed single vessel disease 
involving left circumflex artery. The patient was discharged 
home after the control of symptoms. 
The patient had a regular follow up, and repeat investiga-
tions after one month of treatment showed an ejection frac-
tion of 43%. Moderate fluctuations in the control of blood 
pressure were observed and patient was admitted to the 
intensive care unit for further management of fluctuating 
blood pressure prior to the surgical removal of tht: tumour. 
Preoperatively, most of the symptoms had ameliorated. 
Ortho-static hypotension was within the recommt:nded 
range of 80/45mm Hg, although there were episodes of fluc-
tuating blood pressure. The physician incharge of the case 
suggested to go ahead with surgery as further control of 
blood pressure was not possible. 
On the morning of surgery, the patient was premedicated 
with morphine lOmg intramuscular, midazolam 7.5 mg orally 
alongwith his antihypertensive medications. This resulted in 
a drop of blood pressure to 80/50 mmHg. Following a fluid 
bolus of 500 ml, the B.P. came up to 90/60 mmHg. Patient 
was shifted to O.R. for monitoring. Arterial line was estab-
lished in the left radial artery, for invasive blood pressur-e 
monitoring. Blood pressure ranged between 85-95/55-60 
mmHg. A 1000 ml of fluid was infused, that resulted in blood 
pressure of 100/60 mmHg but patient develop-ed tachycardia, 
with a heart rate of 120-130/min. A swan ganz catheter was 
inserted at this stage. Initial central venous pressure was 3 em 
of water, for which 2.5L fluid was given and central venous 
pressure came upto 6 em of water, cardiac out put was 6.5 L 
and systemic vascular resistance was 550. 
Nordarenaline infusion at the rate of 0.02 ug/kg/min was 
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ltarted to improve the ~ystemic vascular resistance and there-
liter blood pressure rose to 120-130/65-75, heart rate 90/min, 
central venous pressure came upto 10 em of water, cardiac 
out put was lOL/min and the systemic vascular resistance 
Was 650. The Noradrenaline infusion was stopped before 
induction. 
Induction of anaestheia was carried out with midazolam. 
thiopentone, vecuronium, and maintained on isoflurane, 
Vecuronium and morphine. Intra operatively patient 
remained stable until the manipulation of tumour when the 
B.P. shot up from 120/70 to 200-300/100-160 mm of Hg. sodi-
1Um nitroprusside (0.3-6ug/kg/min) infusion was started to 
:control the blood pressure. At time boluses of 50-lOOug were 
l ~ven. With this treatment blood pressure remained fluctuat-mgbetween 250/120 to 130/75mmHg. The resection time was 75 minutes. Following resection of 
the tumor the blood pressure dropped to 90/60 mm Hg. Nor 
adrenaline infusion was restarted at 0.04-0.1ug/kg/min and 
When the blood pressure reached the base line, dose was 
decreased to 0.02ug/kg/min. 
After completion of surgery, the patient was extubated and 
shifted to the ICU with noradrenaline infused at a rate of 0.03-
0.lug/kg/min. The patient had one episode of hypotension 
during the 1st 24 hours, which was corrected by increasing 
noradrenaline infusion. The patient remained stable during 
the 2nd and 3rd post-operative day. On the 3rd post-operative 
day noradrenaline infusion was discontinued. The heamody-
namic parameters of the patient at this stage were as follows, 
blood pressure of 130/70, cardiac index was 3.5, systemic vas-
cular resistance was 925 Dynes/sec/cm5, central venous pres-
sure 10 em water, PAP 25/15 swan ganz catheter and arterial 
line were removed at this stage, patient shifted out of the ICU 
the following day. 
DrscussroN 
Phaeochromocytoma is rare catecholamine secreting 
tumour. Due to continuous or phasic secretion of cate-
cholamine from the tumour, patients present with hyperten-
sive crisis, episodic or sustained hypertension or arrhythmia5• 
Surgical removal of identified lesions should be performed 
under controlled conditions and after sufficient preparation of 
the patient. 
Our patient was managed pre-operatively with Terazocin, 
Tenormin and Rani tee. Terazocin was selected for our patient, 
because of ischaemic heart disease along with phaeochromo-
cytoma. T erazocin in a dose ranging from 1-20mg I day is as 
effective as Prazocin, as it selectively blocks postsynaptic -
alpha lreceptors, it does not produce reflex tachycardia and 
has a shorter duration of action, thereby permitting more 
rapid adjustment of dosage and decreasing the duration of 
post-operative hypotension. Beta blockade for the control of 
preoperative hypertension is only recommended, once the 
alpha 1 adrenergic blockade has been effectively achieved or 
in patients with persistent tachycardia or arrhythmias. Other 
agents recommended for the control preoperative hyperten-
sion are calcium channel blockers6 • These agents reduces 
blood pressure by inhibiting norepinephrine mediated trans-
membrane calcium influx in vascular smooth muscle and not 
by decreasing catecholamines synthesis in tumours7 • The 
main advantage of these agents is that they do not produce 
over shoot hypotension or orthostatic hypotension and can 
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be safely used in normotensive patients who have occasional 
episodes of paroxysmal hypertension. 
The proposed criteria for adequate preoperative preparation 
is to achieve a supine arterial pressure8 not greater than 
160/90 mmHg, orthostatic hypotension not exceeding 80/45 
mmHg, electrocardiogram free of ST -segments or T warve 
changes for atleast 2 weeks and no more than one premature 
ventricular contraction every 5 minutes. We did try to follow 
this criteria but the control of blood pressure was difficult 
even after maximum doses of antihypertensive drug, after 
admission in ICU. As the physician incharge of the case insist-
ed that further control of blood pressure was not possible, 
therefore, the patient was scheduled for surgery. The impor-
tance of adequate volume expansion and proper blood pres-
sure control was further highlighted by the fact that our 
patient did drop his blood pressure on the morning of 
surgery after receiving premedication and antihypertensive 
drugs. This hypotensive episode was treated with non-adren-
aline as 2 L of rapid fluid infusion failed to improve the blood 
pressure. This hypotensive episode before induction was 
treated by using swan ganz catheter for haemodynamic moni-
toring. We had to use noradrenaline in our patient, as even 2 
L of fluid transfusion did not bring the blood pressure up. We 
therefore, recommend that it is beneficial to have an invasive 
arterial pressure monitoring and a PA catheter in place in all 
such patients before induction to control any haemodynamic 
instability during induction, maintenance or following 
removal of the tumour. 
Our patient did have a hypertensive crisis during surgical 
manipulation of the tumour and this was controlled with the 
use of sodium nitropruside and increasing the Isoflurane to 
3%. Hypertension during manipulation of the tumor is due to 
the release of catecholamine and it is treated by nitropruside 
infusion in a dose of 0.5-1ug/kg/min. Nitroprusside is a 
direct acting arteriolar dilating agent with a rapid onset and 
short duration of action and therefore is helpful in cases like 
these where there is a wide and rapid fluctuation in the blood 
pressure. Our patient required much larger doses of sodium 
nitroprusside to control his blood pressure intra-operatively. 
This patient also had an episode of hypotension on removal 
of the tumour, which was controlled by noradrenaline infu-
sion at the rate of 0.04-0.1 ug/kg/min. This was continued 
until the 3rd post-operative day. If the hypotension is persis-
tent then one should rule out hypovolaemia, sudden haemor-
rhage or residual effects of preoperative alpha 1 adrenergic 
blockade. Therefore we recommend initially giving large vol-
umes of 1/V fluids and only then using noradrenaline infu-
sion in such cases. 
In conclusion, management of patients with phaeochromo-
cytoma should focus on the better understanding of patho-
physiology of phaeochromocytoma, better preoperative prepa-
. ration and intraoperative control, and avoidance of drugs that 
causes hypotension or hypertension, use of invasive haemody-
namic monitoring and prompt treatment of hypertensive and 
hypotensive episodes as and when they occur. 
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